Sumpiao, Maribeth B.

HRN: 18-22-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2025
CEFUROXIME 500MG (TAB)
05/26/2025
06/01/2025
PO
500mg
BID X 7 Days
Thickly MSAF; 2nd Degree Perineal Laceration
Waiting Final Action 
05/26/2025
METRONIDAZOLE 500MG (TAB)
05/26/2025
06/01/2025
PO
500mg
TID X 7 Days
Thickly MSAF; 2nd Degree Perineal Laceration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: